Use of insulin glargine during pregnancy
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background. Good metabolic control maintained throughout pregnancy reduces maternal and fetal complications in diabetic women. The long‐acting insulin analogue glargine has 24‐h persistence and a peakless action profile, and could contribute to more stable daily plasma glucose levels and improved glycemic control. We evaluated the metabolic control associated with insulin glargine during pregnancy in comparison with conventional basal insulin therapy. Methods. Retrospective case‐control analysis of glycemic control and pregnancy complications in 100 type 1 diabetic pregnancies with intermediate‐acting NPH insulin or insulin glargine prior to conception and throughout pregnancy. Results. Overall, glycemic control was not different between the groups, though the decrease in HbA1c from the first to the third trimester was greater with insulin glargine (0.8 versus 0.3%, p = 0.04). The rate of hypoglycemia was comparable. Conclusions. Our findings suggest that, as regards metabolic control, insulin glargine in women with type 1 diabetes is comparable with NPH insulin as basal insulin therapy. No adverse effects were associated with glargine use at the time of conception and during pregnancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both of these long-acting insulin analogs, however, are widely used in pregnancy, with evidence of safety in this setting (33–37).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [35]
In the citing paper
“Several retrospective cohort and case-control studies of pregnant women found that overall, the outcome with insulin glargine treatment was no different from, or was superior to, NPH insulin (35, 145–149).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [35]
Citations
Cites
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Hirsch, I. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040832 · Cited by 667
Why Do Diabetic Women Deliver Malformed Infants?
REECE, E. A., & HOMKO, C. J. (2000) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-200003000-00004 · Cited by 343
Pregnancy outcomes in the Diabetes Control and Complications Trial
(1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70683-x · Cited by 278
Preconception Care of Women With Diabetes
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s76 · Cited by 138
Porcellati, F., Rossetti, P., Pampanelli, S., Fanelli, C. G., Torlone, E., Scionti, L., Perriello, G., & Bolli, G. B. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01323.x · Cited by 129
Type I diabetes mellitus and pregnancy
Garner, P. R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91213-4 · Cited by 125
Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
Kitzmiller, J. L., Main, E. K., Ward, B., Theiss, T. S., & Peterson, D. L. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.874 · Cited by 95
Use of insulin glargine during pregnancy: a case-control pilot study
Price, N., Bartlett, C., & Gillmer, M. (2007) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01216.x · Cited by 93
Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro
Loukovaara, S., Immonen, I., Teramo, K. A., & Kaaja, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1193 · Cited by 80
Self-citation
Cited by
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
Martis, R., Crowther, C. A., Shepherd, E., Alsweiler, J., Downie, M. R., & Brown, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012327.pub2 · Cited by 159
Safety of Insulin Glargine Use in Pregnancy: A Systematic Review and Meta-Analysis
Pollex, E., Moretti, M. E., Koren, G., & Feig, D. S. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p327 · Cited by 116
Insulin Glargine Safety in Pregnancy
Pollex, E. K., Feig, D. S., Lubetsky, A., Yip, P. M., & Koren, G. (2010) · Diabetes Care · doi:10.2337/dc09-1045 · Cited by 104
Hypoglycaemia during pregnancy in women with Type 1 diabetes
Ringholm, L., Pedersen‐Bjergaard, U., Thorsteinsson, B., Damm, P., & Mathiesen, E. R. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03604.x · Cited by 101
Metadata
- Authors
- PÖYHÖNEN‐ALHO, M., RÖNNEMAA, T., SALTEVO, J., EKBLAD, U., & KAAJA, R. J.
- Affiliations
- Helsinki University Hospital (FI)
- Turku University Hospital (FI)
- Central Finland Health Care District (FI)
- Corresponding author
- PÖYHÖNEN‐ALHO, MARITTA
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 2007-10
- Volume
- 86
- Issue
- 10
- Pages
- 1171-1174
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W2126199017
- Cited by
- 52
- References
- 18
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 1 · 2013: 5 · 2012: 5
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Acta Obstetricia Et Gynecologica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- insulin glargine, type 1 diabetes, pregnancy, glycemic control, HbA1c, NPH insulin, basal insulin therapy, hypoglycemia, pregnancy complications, long-acting insulin analogues
- MeSH terms
- Insulin Glargine, Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemic Agents, Pregnancy, Pregnancy in Diabetics, Retrospective Studies, Case-Control Studies, Insulin, Long-Acting, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of insulin glargine during pregnancy. https://app.cochat.ai/papers/10.1080/00016340701515282
- The paper
- PÖYHÖNEN‐ALHO, M., RÖNNEMAA, T., SALTEVO, J., EKBLAD, U., & KAAJA, R. J. (2007). Use of insulin glargine during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1080/00016340701515282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.